# Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients

> **NCT00411853** · PHASE2 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Hormone Refractory Prostate Cancer

## Interventions

- **DRUG:** Fermented Wheat germ extract

## Key facts

- **NCT ID:** NCT00411853
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-06
- **Primary completion:** 2011-06
- **Final completion:** 2012-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00411853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00411853, "Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00411853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*